Pupillometry in Delayed Sleep Wake Phase Disorder

NANot yet recruitingINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

February 28, 2029

Study Completion Date

July 31, 2029

Conditions

Delayed Sleep-Wake Phase Disorder

Interventions

COMBINATION_PRODUCT

Light and Citalopram

Participants will receive placebo or citalopram, followed by bright light exposure

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Northwestern University

OTHER

NCT06949644 - Pupillometry in Delayed Sleep Wake Phase Disorder | Biotech Hunter | Biotech Hunter